|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221.5 USD | -0.56% |
|
+1.83% | -14.40% |
| May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
| May. 08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
Biogen Inc. announced that Dr. Papadopoulos is not standing for reelection at the 2023 Annual Meeting. Effective immediately after the 2023 Annual Meeting, Ms. Dorsa will become Chair of the Board. Ms. Dorsa resigned from the Board of Directors of Intellia Therapeutics Inc. The resignation will be effective on June 15, 2023.
Mr. Viehbacher is not standing for reelection for the Board of Directors of Puretech plc and will depart the Puretech plc Board on June 13, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.40% | 32.25B | |
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B | |
| -3.16% | 8.62B |
BIOGEN INC. 